ASX:ANR - Anatara Lifesciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Anatara Lifesciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day RangeA$0.24MA: A$0.28▼A$0.4052-Week Range N/AVolume48,600 shsAverage VolumeN/AMarket Capitalization$12.64 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. Its lead product includes Detach, a non-antibiotic treatment to aid in the control of diarrhoeal diseas. The company is also developing bromelain formulations for gastrointestinal health. Anatara Lifesciences Limited is based in Brisbane, Australia. Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:ANR Previous Symbol CUSIPN/A CIKN/A Webhttp://www.anataralifesciences.com/ Phone61 7 3394 8202Debt Debt-to-Equity RatioN/A Current Ratio14.03 Quick Ratio13.93Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$663,405.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.29 Book ValueA$0.12 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares49,562,700Market Cap$12.64 million Next Earnings DateN/A OptionableNot Optionable Receive ANR News and Ratings via Email Sign-up to receive the latest news and ratings for ANR and its competitors with MarketBeat's FREE daily newsletter. Anatara Lifesciences (ASX:ANR) Frequently Asked Questions What is Anatara Lifesciences' stock symbol? Anatara Lifesciences trades on the ASX under the ticker symbol "ANR." Has Anatara Lifesciences been receiving favorable news coverage? News coverage about ANR stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Anatara Lifesciences earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Anatara Lifesciences. Who are some of Anatara Lifesciences' key competitors? Some companies that are related to Anatara Lifesciences include Zelda Therapeutics (ZLD), Protalix Biotherapeutics (PLX), Tiziana Life Sciences (TILS), ReNeuron Group (RENE), 4d Pharma (DDDD), Emerald Health Therapeutics (EMH), Actinium Pharmaceuticals (ATNM), Actinium Pharmaceuticals (ATNM), Armata Pharmaceuticals (ARMP), Covalon Technologies (COV), Noxopharm (NOX), Kazia Therapeutics (KZA), Immunoprecise Antibodies (IPA), Mereo BioPharma Group (MPH) and AquaBounty Technologies (AQB). What other stocks do shareholders of Anatara Lifesciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Brompton Oil Split Cl A (OSP), Eagle Materials (EXP), BHP Group (BHP), Ameriprise Financial (AMP) and Woodside Petroleum (WPL). Who are Anatara Lifesciences' key executives? Anatara Lifesciences' management team includes the folowing people: Dr. Tracie Elizabeth Ramsdale, Interim CEO & Exec. Director (Age 56)Dr. Tracey Mynott, Co-Founder, Chief Scientific Officer and R&D DirectorDr. Michael L. West Ph.D., Chief Operating Officer (Age 55)Dr. Terence Jean Brown, Chief Devel. Officer (Age 56)Mr. Alan Dowling, Group Accountant How big of a company is Anatara Lifesciences? Anatara Lifesciences has a market capitalization of $0.00 and generates $663,405.00 in revenue each year. View Additional Information About Anatara Lifesciences. What is Anatara Lifesciences' official website? The official website for Anatara Lifesciences is http://www.anataralifesciences.com/. How can I contact Anatara Lifesciences? The company can be reached via phone at 61 7 3394 8202. MarketBeat Community Rating for Anatara Lifesciences (ASX ANR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 12 (Vote Outperform)Underperform Votes: 13 (Vote Underperform)Total Votes: 25MarketBeat's community ratings are surveys of what our community members think about Anatara Lifesciences and other stocks. Vote "Outperform" if you believe ANR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2020 by MarketBeat.com StaffFeatured Article: How much money do you need to begin day trading?
